NCT02466711

Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

A Single-center, Placebo-controlled, Double-blind Study to Evaluate the Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Motus Therapeutics, Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the effects of relamorelin (RM-131) on gastric volume, motor and sensory effects in healthy patients.

Conditions

• Gastric Motility

Interventions

Type	Name	Description
DRUG	Relamorelin	Double blind RM-131 will be delivered three times by injection during the course of the study
DRUG	Placebo	Double blind Placebo will be delivered three times by injection during the course of the study

Timeline

• Start date: 2015-06-01
• Primary completion: 2015-08-01
• Completion: 2015-09-01
• First posted: 2015-06-09
• Last updated: 2016-09-22

Locations

1 site across 1 country: United States